Share & Key figures
Marinomed Biotech AG has been listed on the Vienna Stock Exchange since 1 February 2019. The shares are listed in the Prime Market segment and included in the ATX Prime Index.
| Share data | |
| ISIN | ATMARINOMED6 |
| Share class | No-par bearer shares |
| Nominal capital | EUR 1,469,772 (1,469,772 no-par value shares) |
| Ticker symbol | MARI |
| Issue price (IPO) on 1.2.2019 | EUR 75.00 |
| Market capitalization (at issue price) | EUR 97.4 Mio. |
For current price information please follow the link to the website of the Vienna Stock Exchange.
Coverage
Erste Group (Vladimira Urbankova)
goetzpartners securities Limited (Brigitte de Lima)
Kepler Cheuvreux (Arsene Guekam)
| Selected key financial figures | ||
| in EUR Mio. | 2018 | 2017 |
| Revenues | 4.67 | 4.81 |
| Operating result (EBIT) | -5.14 | -1.64 |
| Loss for the year | -12.10 | -2.38 |
| Adjusted annual result 1) | -4.56 | |
| Cash and cash equivalents per 31.12. | 1.72 | 6.03 |
| Balance sheet total per 31.12. | 5.26 | 9.33 |
| Net cash flow | -4.31 | 4.02 |
1) Adjusted annual result, excluding one-off special effects (valuation of the convertible bond and IPO costs)